Showing results (11-20 of 47) with videos related to
Sort By:
Pageof 5
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|April 17, 2015
[Epidemiological characteristics of enterovirus type 71 diseases]Zhengkai Gan, Jingxin Li, Fanyue Meng, et al.Human Vaccines & Immunotherapeutics|February 22, 2022
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered in a prime-boost regimen among Chinese infants: a randomized, double blind phase III clinical trialWenjuan Wang, Qi Liang, Jiahong Zhu, et al.Human Vaccines & Immunotherapeutics|February 26, 2015
Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in 2 to 70 year old healthy people in China: A phase III double blind, randomized clinical trialGuifan Li, Qi Liang, Jichun Shi, et al.Expert Review of Vaccines|April 16, 2021
Cross-neutralization Capacity of Immune Serum from Different Dosage of Sabin Inactivated Poliovirus Vaccine Immunization against Multiple Individual PoliovirusesKai Chu, Weixiao Han, Deyu Jiang, et al.Journal of Robotic Surgery|January 4, 2026
Perioperative outcomes of robotic-assisted versus traditional surgery for DIEP flap breast reconstruction: a systematic review and meta-analysisXia Xu, Jing Hou, ZongYing Lv, et al.Human Vaccines & Immunotherapeutics|February 28, 2018
Five-year immunity persistence following immunization with inactivated enterovirus 71 type (EV71) vaccine in healthy children: A further observationYuemei Hu, Gang Zeng, Kai Chu, et al.Human Vaccines & Immunotherapeutics|July 27, 2019
Immunogenicity and safety of a meningococcal serogroups A and C tetanus toxoid conjugate vaccine (MenAC-TT): two immune schedules in toddles aged 12-23 months in ChinaJialei Hu, Hongguang Li, Kai Chu, et al.International Journal of Clinical and Experimental Medicine|February 18, 2016
Clinical significance of urothelial carcinoma associated 1 in colon cancerKun Tao, Jing Yang, Yuemei Hu, et al.Vaccine|August 1, 2020
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: A randomized, double-blind, controlled phase III study in healthy population aged ≥3 yearsKai Chu, Kangwei Xu, Rong Tang, et al.Human Vaccines & Immunotherapeutics|April 30, 2020
A phase Ⅱ, randomized, controlled trial to evaluate the safety and immunogenicity of a Sabin strain-based inactivated polio vaccineRong Tang, Guifan Li, Chengfu Zhang, et al.Pageof 5